|
Consequences of BETonMACE Findings
|
1
|
Resverlogix Corp.
|
May 10, 2016 01:26PM
|
|
Re: For those complaining about the money DM makes....
|
3
|
Resverlogix Corp.
|
May 07, 2016 11:54AM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
5
|
Resverlogix Corp.
|
May 06, 2016 03:15PM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
4
|
Resverlogix Corp.
|
May 05, 2016 08:01PM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
3
|
Resverlogix Corp.
|
May 05, 2016 05:18PM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
4
|
Resverlogix Corp.
|
May 05, 2016 05:05PM
|
|
Re: How I See It
|
5
|
Resverlogix Corp.
|
May 04, 2016 03:41PM
|
|
Re: Two investor conferences May 2
|
4
|
Resverlogix Corp.
|
May 01, 2016 03:39PM
|
|
Re: Resverlogix NYAS Symposium notes
|
1
|
Resverlogix Corp.
|
Apr 30, 2016 09:36AM
|
|
Re: Should I do a blog posting about Resverlogix?
|
2
|
Resverlogix Corp.
|
Apr 30, 2016 09:33AM
|
|
Re: Zenith NYAS Symposium notes
|
3
|
Zenith Epigenetics
|
Apr 29, 2016 06:56PM
|
|
Re: Resverlogix NYAS Symposium notes
|
2
|
Resverlogix Corp.
|
Apr 29, 2016 03:06PM
|
|
Re: Interesting Uptick
|
4
|
Resverlogix Corp.
|
Apr 28, 2016 04:00PM
|
|
Re: Interesting Uptick
|
4
|
Resverlogix Corp.
|
Apr 28, 2016 01:44PM
|
|
Re: Hepalink Anniversary - Apr 27
|
3
|
Resverlogix Corp.
|
Apr 26, 2016 01:34PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
1
|
Resverlogix Corp.
|
Apr 20, 2016 01:09PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
2
|
Resverlogix Corp.
|
Apr 20, 2016 09:36AM
|
|
Re: Q2 Zenith/Resverlogix Events
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 08:53AM
|
|
Re: Q2 Zenith/Resverlogix Events
|
2
|
Zenith Epigenetics
|
Apr 12, 2016 05:10PM
|
|
Re: Stock Sales
|
2
|
Resverlogix Corp.
|
Apr 09, 2016 05:07PM
|
